Cancer

Researchers Develop Blood Test That May Detect Testicular Cancer Missed by Standard Markers

Mayo Clinic researchers have developed a blood test that detected 93% of germ cell tumors—including cases missed by standard markers.

Cancer

Amplified Sciences Receives CAP Accreditation for Clinical Diagnostic Laboratory

Amplified Sciences has received CAP accreditation for its clinical laboratory, enabling broader commercial deployment of its PanCystPro assay for pancreatic cancer risk assessment, the company announced.

Cancer

AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

The assay predicts both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.

Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test

Apr 17, 2026 | Colorectal, Molecular Diagnostics

The Idylla CDx MSI Test detects microsatellite instability in colorectal cancer tissue in under three hours, supporting therapy selection for eligible patients.

CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials

Apr 17, 2026 | Cancer, Lung Cancer, Molecular Diagnostics

CellCarta has secured exclusive global rights to deploy Biofidelity’s Aspyre Lung assay in lung cancer clinical trials, streamlining genomic testing for trial sponsors and reducing reliance on multiple vendors.

Seed Funding to Advance Biopsy Catchment Technology and Liquid Specimen Biorepository

Apr 17, 2026 | Anatomic Pathology, Cancer, Molecular Diagnostics

A $4 million financing round will support development of a liquid specimen biorepository and expand biopsy catchment pilot programs at medical institutions across the US.

ViewsML to Present Virtual Staining Research at AACR 2026

Apr 16, 2026 | Anatomic Pathology, Cancer, Digital Pathology

ViewsML will present research on its AI-powered virtual immunohistochemistry platform at AACR 2026, highlighting biomarker detection from routine H&E slides without traditional staining.

GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing

Apr 15, 2026 | Cancer, Company News, Molecular Diagnostics

Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.

NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026

Apr 15, 2026 | Cancer, Digital Pathology, Molecular Diagnostics

Presentations at the upcoming annual meeting will focus on AI-based analysis, biomarker prevalence, and therapy development.

Labcorp and Children’s Hospital of Philadelphia Partner to Expand Pediatric Diagnostic Access

Apr 14, 2026 | Cancer, Company News, Diagnostic Technologies

The collaboration aims to create an innovation pipeline for specialized pediatric tests across oncology, metabolic disease, and autoimmune conditions.

Ataraxis AI Launches Test to Predict Response to Neoadjuvant Therapy in Breast Cancer

Apr 10, 2026 | Breast

The tool uses digitized pathology slides to estimate how patients will respond to therapy before surgery.

Blood-Based Biomarker Identifies Cancer Risk in Lynch Syndrome Patients

Apr 9, 2026 | Cancer

Researchers at MD Anderson have identified a blood-based biomarker using T cell receptor sequencing that may help assess cancer risk in asymptomatic Lynch syndrome carriers, according to a study in Nature Communications.

FDA Clears At-Home Cervical Cancer Screening Tool

Apr 8, 2026 | Cervical (HPV)

The clearance of the Onclarity HPV Self-Collection Kit and approval of the BD Onclarity HPV Assay aim to reduce barriers for unscreened populations.

Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform

Apr 7, 2026 | Cancer

20/20 BioLabs’ AI-powered multi-cancer early detection test, OneTest for Cancer, is now available to approximately 40,000 clinicians via the Evexia Diagnostics platform.

New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026

Apr 7, 2026 | Cancer, Lung Cancer, Molecular Diagnostics

Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.

DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging

Apr 6, 2026 | Melanoma

Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.

EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study

Apr 6, 2026 | Prostate

The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.

Home HPV Self-Sampling Kits Show Promise for Closing Cervical Screening Gap in Disabled Women

Apr 2, 2026 | Cervical (HPV)

A new survey-based study finds that more than half of physically Disabled women would prefer at-home human papillomavirus testing over traditional clinic-based cervical screening.

Category: Cancer

Cancer

Cancer

Cancer